OECD TG 443

OECD TG 443 is the standard for the ‘Extended One-Generation Reproductive Toxicity Study’ (EOGRTS), i.e. the extended one-generation reproductive toxicity study, which is included in Section 4 (Health Effects) of the OECD Test Guidelines for the Testing of Chemicals. Adopted in 2011 and updated in 2018, the guideline is designed as a testing standard intended to replace the previous two-generation studies (TG 415 and TG 416) and offers a more flexible cohort structure as well as a more comprehensive catalogue of endpoints.

Das Grundprinzip des Tests besteht darin, die Testsubstanz bereits ab der Zeit vor der Paarung an die Elterngeneration (P) zu verabreichen, diese zu paaren und die F1-Generation in utero und über die Milch der Mutter der Substanz auszusetzen. Falls erforderlich, können die F1-Nachkommen nach dem Absetzen auch einer direkten Dosierung unterzogen werden. Die Studie wird in der Regel an Ratten carried out.

The key innovation of the EOGRTS is its cohort-based design. The cohorts are activated or deactivated depending on conditional triggers:

Cohort 1A (Reproduction and Development Cohort):

  • Parameters relating to mating, fertility and conception
  • Oestrus cycle, sperm parameters
  • Data on pregnancy, birth and lactation
  • Postnatal development in F1 offspring (body weight, survival rate)
  • Anogenital distance (AGD) and number of teats
  • Pubertal development (vaginal opening, splitting of the prepuce)
  • Thyroid hormone levels (T4, TSH)
  • Weights and histopathology of the reproductive organs and related organs

Cohort 1B (optional reproductive cohort):

  • An additional cohort without extended histopathology, focusing on reproductive functions
  • Used to enhance data reliability in specific regulatory contexts

Cohort 2A (Developmental neurotoxicity – DNT):

  • Motor activity, acoustic startle reflex (auditory startle reflex)
  • Learning and memory tests (e.g. the Morris water maze)
  • Brain weight and neuropathological examination
  • Is only activated in the event of a structural alert or when triggered by previous data

Cohort 2B (optional DNT cohort):

  • Behavioural assessment without neuropathology

Cohort 3 (Developmental Immunotoxicity – DIT):

  • T-cell-dependent antibody response (TDAR)
  • Immunophenotyping
  • NK cell activity
  • Is only activated if there are indications of immunotoxicity

This cohort structure aims to significantly reduce the number of animals used compared with two-generation studies (the literature cites a reduction of up to approximately 40 per cent) whilst at the same time broadening the scientific scope. The establishment of the cohorts is justified on the basis of the structural properties of the test substance, previous toxicity data and regulatory requirements.

The study design includes a negative control group, a solvent control group and, where appropriate, a positive control group.

Why is it carried out?

OECD TG 443 is being carried out for the following scientific and regulatory purposes:

  • Comprehensive characterisation of reproductive and developmental toxicity: a holistic assessment of fertility, pregnancy, lactation and F1 development in a single study
  • Investigation of endocrine effects: assessment of endocrine activity using sensitive endpoints such as AGD, number of teats, timing of puberty and thyroid hormone levels
  • Assessment of developmental neurotoxicity (DNT): Evaluation of neurodevelopmental effects using behavioural and neuropathological endpoints
  • Assessment of development-related immunotoxicity (DIT): Investigation of immune system development using TDAR and immunophenotyping
  • Support with regulatory documentation: Use in REACH, plant protection product, biocidal product and medicinal product safety assessments
  • Reducing the need for animal testing (3Rs): obtaining more comprehensive data using fewer animals compared with two-generation studies
  • The ‘weight-of-evidence’ approach: a contribution to risk assessment in conjunction with other toxicity data, physicochemical properties and an exposure assessment

As part of our nano-testing services, we carry out studies in accordance with OECD Guideline TG 443, applying scientific rigour and utilising our accredited laboratory facilities and quality management system. Our scope of services includes the following:

Study design and protocol development

Preparation of a test protocol and a cohort design in accordance with OECD TG 443

Determination of the dosage range and the main test design in accordance with the physicochemical properties of the test substance and the regulatory requirements

Scientific rationale for the triggers for Cohort 2A (DNT) and Cohort 3 (DIT)

Specification of the negative control, the solvent control and, where appropriate, suitable positive control groups; scientific justification for the animal species, route of administration, dosages and duration of administration; compliance with the requirements regarding ethical approval and animal welfare